Link Between Reduction of Suicide Ideation by Esketamine in Add-On and Initial Levels of Psychological Pain and Anhedonia
Active, not recruitingOBSERVATIONAL
Enrollment
456
Participants
Timeline
Start Date
November 24, 2024
Primary Completion Date
November 24, 2025
Study Completion Date
November 24, 2025
Conditions
Depression - Major Depressive DisorderDepression DisorderSuicide
Trial Locations (1)
Unknown
Chu Montpellier, Montpellier
All Listed Sponsors
lead
University Hospital, Montpellier
OTHER
NCT07199179 - Link Between Reduction of Suicide Ideation by Esketamine in Add-On and Initial Levels of Psychological Pain and Anhedonia | Biotech Hunter | Biotech Hunter